Early study reveals promising Alzheimer's disease treatment

A drug once approved as an antihistamine in Russia improved thinking processes and ability to function in patients with Alzheimer's disease in a study conducted there, said an expert at Baylor College of Medicine in Houston. The findings are published in the current issue of the journal The Lancet.

Read the whole article

See latest science articles from Physorg

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox!

Related